jrnl2149

Publication Venue For

  • Preclinical efficacy of dual mTORC1/2 inhibitor AZD8055 in renal cell carcinoma harboring a TFE3 gene fusion.  19:917. 2019
  • Geospatial analyses identify regional hot spots of diffuse gastric cancer in rural Central America.  19. 2019
  • Overall survival of patients with recurrent pancreatic cancer treated with systemic therapy: A retrospective study.  19. 2019
  • Interleukin 8 is a biomarker of telomerase inhibition in cancer cells.  18. 2018
  • Predicting multi-level drug response with gene expression profile in multiple myeloma using hierarchical ordinal regression.  18. 2018
  • Metabolic dysregulation and cancer mortality in a national cohort of blacks and whites.  17. 2017
  • An analysis of 97 previously diagnosed de novo adult acute erythroid leukemia patients following the 2016 revision to World Health Organization classification.  17. 2017
  • Sertad1 antagonizes iASPP function by hindering its entrance into nuclei to interact with P53 in leukemic cells.  17. 2017
  • Cancer-related risk factors and incidence of major cancers by race, gender and region; analysis of the NIH-AARP diet and health study.  17. 2017
  • Genome-wide DNA methylation measurements in prostate tissues uncovers novel prostate cancer diagnostic biomarkers and transcription factor binding patterns.  17. 2017
  • Erratum: Feasibility outcomes of a presurgical randomized controlled trial exploring the impact of caloric restriction and increased physical activity versus a wait-list control on tumor characteristics and circulating biomarkers in men electing prostatectomy for prostate cancer. [BMC Cancer, 16 (2016) (61)].  17. 2017
  • Living well after breast cancer randomized controlled trial protocol: Evaluating a telephone-delivered weight loss intervention versus usual care in women following treatment for breast cancer.  16. 2016
  • Connect MDS/AML: Design of the myelodysplastic syndromes and acute myeloid leukemia disease registry, a prospective observational cohort study.  16. 2016
  • Survival rates of cancer patients with and without rheumatic disease: A retrospective cohort analysis.  16. 2016
  • A comparison of 12-gene colon cancer assay gene expression in African American and Caucasian patients with stage II colon cancer.  16. 2016
  • Feasibility outcomes of a presurgical randomized controlled trial exploring the impact of caloric restriction and increased physical activity versus a wait-list control on tumor characteristics and circulating biomarkers in men electing prostatectomy for prostate cancer.  16. 2016
  • Healthy Living after Cancer: A dissemination and implementation study evaluating a telephone-delivered healthy lifestyle program for cancer survivors.  15. 2015
  • Enhancement of Cetuximab-Induced Radiosensitization by JAK-1 Inhibition.  15. 2015
  • Epigenetic-based combinatorial resveratrol and pterostilbene alters DNA damage response by affecting SIRT1 and DNMT enzyme expression, including SIRT1-dependent γ-H2AX and telomerase regulation in triple-negative breast cancer.  15. 2015
  • Weight and weight change following breast cancer: Evidence from a prospective, population-based, breast cancer cohort study.  15. 2015
  • A multi-center population-based case-control study of ovarian cancer in African-American women: The African American Cancer Epidemiology Study (AACES).  14. 2014
  • Variable NF-κB pathway responses in colon cancer cells treated with chemotherapeutic drugs.  14. 2014
  • Randomized controlled trial to evaluate the effects of combined progressive exercise on metabolic syndrome in breast cancer survivors: Rationale, design, and methods.  14. 2014
  • N-glycosylation of ICAM-2 is required for ICAM-2-mediated complete suppression of metastatic potential of SK-N-AS neuroblastoma cells.  13. 2013
  • IL-11 produced by breast cancer cells augments osteoclastogenesis by sustaining the pool of osteoclast progenitor cells.  13. 2013
  • Cytoplasmic BRMS1 expression in malignant melanoma is associated with increased disease-free survival.  12. 2012
  • Early dissemination of bevacizumab for advanced colorectal cancer: A prospective cohort study.  11. 2011
  • A novel tumor suppressor gene ECRG4 interacts directly with TMPRSS11A (ECRG1) to inhibit cancer cell growth in esophageal carcinoma.  11. 2011
  • Gene expression profiling identifies inflammation and angiogenesis as distinguishing features of canine hemangiosarcoma.  10. 2010
  • Early termination of ISRCTN45828668, a phase 1/2 prospective, randomized study of sulfasalazine for the treatment of progressing malignant gliomas in adults.  9:372. 2009
  • Characterization of SV-40 Tag rats as a model to study prostate cancer.  9. 2009
  • The Adnectin CT-322 is a novel VEGF receptor 2 inhibitor that decreases tumor burden in an orthotopic mouse model of pancreatic cancer.  8. 2008
  • Ancestry reported by white adults with cutaneous melanoma and control subjects in central Alabama.  4. 2004
  • Characterization of human mesothelin transcripts in ovarian and pancreatic cancer.  4. 2004